Cargando…

Expression and clinical significance of HCCS1 in non-small cell lung cancer

AIM OF THE STUDY: Hepatocellular carcinoma suppressor 1 (HCCS1) has been identified as a tumor suppressor gene in the high-frequency loss of heterozygosity (LOH) region on chromosome 17p13.3 in hepatocellular carcinoma (HCC). There was also a high frequency of LOH on chromosome 17p13.3 in non-small...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao-Yong, Shen, Zhi-Feng, Lin, Fan-zhen, Lu, Zhen, Ruan, Jian, Zhen, Hai-long, Huang, Chao-qiang, Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687437/ https://www.ncbi.nlm.nih.gov/pubmed/23788903 http://dx.doi.org/10.5114/wo.2012.30062

Ejemplares similares

Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs
por: Carr, Brian I., et al.
Publicado: (2021)

The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and Beyond
por: Alfano, Vincenzo, et al.
Publicado: (2021)

Pulmonary sarcomatoid carcinoma: a case report
por: Shen, Xiao-yong, et al.
Publicado: (2013)

A faulty interaction between SOD1 and hCCS in neurodegenerative disease
por: Wright, Gareth S. A., et al.
Publicado: (2016)

Qualitative analysis of small (≤2 cm) regenerative nodules, dysplastic nodules and well-differentiated HCCs with gadoxetic acid MRI
por: Di Martino, Michele, et al.
Publicado: (2016)

The impairment of HCCS leads to MLS syndrome by activating a non-canonical cell death pathway in the brain and eyes
por: Indrieri, Alessia, et al.
Publicado: (2013)

The impairment of HCCS leads to MLS syndrome by activating a non-canonical cell death pathway in the brain and eyes
por: Indrieri, Alessia, et al.
Publicado: (2014)

Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P
por: Liu, Yewei, et al.
Publicado: (2017)

Delta-like 3 is silenced by HBx via histone acetylation in HBV-associated HCCs
por: Hamamoto, Hiroki, et al.
Publicado: (2018)

Significant Roles of Regulatory T Cells and Myeloid Derived Suppressor Cells in Hepatitis B Virus Persistent Infection and Hepatitis B Virus-Related HCCs
por: Kondo, Yasuteru, et al.
Publicado: (2015)

Molecular recognition and maturation of SOD1 by its evolutionarily destabilised cognate chaperone hCCS
por: Sala, Fernanda A., et al.
Publicado: (2019)

Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors
por: Liu, Yong-Qiang, et al.
Publicado: (2015)

HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy
por: Xu, Hai-Neng, et al.
Publicado: (2011)

Update on liquid biopsy in clinical management of non-small cell lung cancer
por: Wu, Zhen, et al.
Publicado: (2019)

Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer
por: Xiao, Hai-Fan, et al.
Publicado: (2017)

Promoter Methylation of MLH1, PMS2, MSH2 and p16 Is a Phenomenon of Advanced-Stage HCCs
por: Hinrichsen, Inga, et al.
Publicado: (2014)

Effect of body mass index on survival of patients with stage I non-small cell lung cancer
por: Xie, Hao-Jun, et al.
Publicado: (2017)

Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors
por: Li, Zhen-ye, et al.
Publicado: (2013)

Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer
por: Zhou, Zhen, et al.
Publicado: (2012)

Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows
por: Granata, Vincenza, et al.
Publicado: (2017)

Neoadjuvant Programmed Cell Death Protein 1 Blockade Combined With Stereotactic Body Radiation Therapy for Stage III(N2) Non-Small Cell Lung Cancer: A Case Series
por: Wang, Zhen, et al.
Publicado: (2022)

The Expression and Related Clinical Significance of SIRT3 in Non-Small-Cell Lung Cancer
por: Yang, Guo-Cai, et al.
Publicado: (2017)

Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome
por: van Rahden, Vanessa A, et al.
Publicado: (2014)

Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice
por: Li, He, et al.
Publicado: (2018)

Clinical significance of serum soluble death receptor 5 concentration in locally advanced non-small cell lung cancer patients
por: YU, XINSHUANG, et al.
Publicado: (2014)

Expression of Cystatin SN significantly correlates with recurrence, metastasis, and survival duration in surgically resected non-small cell lung cancer patients
por: Cao, Xun, et al.
Publicado: (2015)

Non-invasive detection of EGFR and TP53 mutations through the combination of plasma, urine and sputum in advanced non-small cell lung cancer
por: Wu, Zhen, et al.
Publicado: (2019)

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer
por: Kang, Jin, et al.
Publicado: (2020)

Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study
por: Fan, Heng, et al.
Publicado: (2015)

Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
por: Chen, Peng, et al.
Publicado: (2014)

Prediction of the Mechanism of Sodium Butyrate against Radiation-Induced Lung Injury in Non-Small Cell Lung Cancer Based on Network Pharmacology and Molecular Dynamic Simulations
por: Zhang, Xiao-zhen, et al.
Publicado: (2022)

Hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer
por: Jiang, Wei, et al.
Publicado: (2015)

Heterogeneous responses and resistant mechanisms to crizotinib in ALK‐positive advanced non‐small cell lung cancer
por: Kang, Jin, et al.
Publicado: (2018)

New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
por: Jiang, Piao, et al.
Publicado: (2023)

Intracardiac Metastasis From Non-Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2015)

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer
por: Liu, Yi-Zhen, et al.
Publicado: (2016)

A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer
por: Guo, Xiao-Fang, et al.
Publicado: (2017)

Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations
por: Lou, Na-Na, et al.
Publicado: (2016)

Expression and significance of SOX2 in non-small cell lung carcinoma
por: Ying, Jie, et al.
Publicado: (2016)

Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients
por: Wang, Zhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_77or49b1i56v1fc2p8jqj5q5u5